Compile Data Set for Download or QSAR
Report error Found 705 Enz. Inhib. hit(s) with all data for entry = 12168
TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684451BDBM684451(US20240218021, Example 669)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684390BDBM684390(US20240218021, Example 638)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684322BDBM684322(US20240218021, Example 257)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684066BDBM684066(US20240218021, Example 129)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-dependent kinase 1/G2/mitotic-specific cyclin-B(Spiny starfish)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 683991BDBM683991(US20240218021, Example 438)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684206BDBM684206(US20240218021, Example 199)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 683885BDBM683885(US20240218021, Example 385)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684271BDBM684271(US20240218021, Example 578)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684499BDBM684499(US20240218021, Example 693)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684374BDBM684374(US20240218021, Example 630)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684437BDBM684437(US20240218021, Example 662)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-dependent kinase 1/G2/mitotic-specific cyclin-B(Spiny starfish)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684220BDBM684220(US20240218021, Example 206)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 683985BDBM683985(US20240218021, Example 435)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684497BDBM684497(US20240218021, Example 692)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 683987BDBM683987(US20240218021, Example 436)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-dependent kinase 1/G2/mitotic-specific cyclin-B(Spiny starfish)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684472BDBM684472(US20240218021, Example 333)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-dependent kinase 1/G2/mitotic-specific cyclin-B(Spiny starfish)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 683811BDBM683811(US20240218021, Example 348)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684313BDBM684313(US20240218021, Example 599)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684376BDBM684376(US20240218021, Example 631)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-dependent kinase 1/G2/mitotic-specific cyclin-B(Spiny starfish)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684383BDBM684383(US20240218021, Example 288)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684315BDBM684315(US20240218021, Example 600)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684378BDBM684378(US20240218021, Example 632)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-dependent kinase 1/G2/mitotic-specific cyclin-B(Spiny starfish)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684468BDBM684468(US20240218021, Example 331)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684483BDBM684483(US20240218021, Example 685)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684040BDBM684040(US20240218021, Example 116)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684479BDBM684479(US20240218021, Example 683)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684492BDBM684492(US20240218021, Example 343)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684491BDBM684491(US20240218021, Example 689)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684493BDBM684493(US20240218021, Example 690)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 683983BDBM683983(US20240218021, Example 434)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684360BDBM684360(US20240218021, Example 623)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 683979BDBM683979(US20240218021, Example 432)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684467BDBM684467(US20240218021, Example 677)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684465BDBM684465(US20240218021, Example 676)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684412BDBM684412(US20240218021, Example 303)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684351BDBM684351(US20240218021, Example 618)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684471BDBM684471(US20240218021, Example 679)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684347BDBM684347(US20240218021, Example 616)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684155BDBM684155(US20240218021, Example 520)
Affinity DataIC50: 20nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684388BDBM684388(US20240218021, Example 637)
Affinity DataIC50: 30nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684258BDBM684258(US20240218021, Example 225)
Affinity DataIC50: 30nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684003BDBM684003(US20240218021, Example 444)
Affinity DataIC50: 30nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684067BDBM684067(US20240218021, Example 476)
Affinity DataIC50: 30nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684074BDBM684074(US20240218021, Example 133)
Affinity DataIC50: 30nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684012BDBM684012(US20240218021, Example 102)
Affinity DataIC50: 30nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684307BDBM684307(US20240218021, Example 596)
Affinity DataIC50: 30nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684364BDBM684364(US20240218021, Example 625 | US20240218021, Exampl...)
Affinity DataIC50: 30nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684062BDBM684062(US20240218021, Example 127)
Affinity DataIC50: 30nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 684064BDBM684064(US20240218021, Example 128)
Affinity DataIC50: 30nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 683999BDBM683999(US20240218021, Example 442)
Affinity DataIC50: 30nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

Displayed 1 to 50 (of 705 total ) | Next | Last >>
Jump to: